Integrative bioinformatics and experimental analysis identify S100A10 as a diagnostic and prognostic biomarker in pancreatic adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is an extremely invasive malignancy with limited effective treatment options. S100 calcium-binding protein A10 (S100A10), a protein-coding gene, plays a critical role in tumor progression. However, its correlation with immune cell infiltration and PAAD prognosis has not been previously reported.